Annual cost of flu

The annual direct and indirect cost of flu in the U.S. is more than $87 billion.

Molinari, Noelle-Angelique M., Ismael R. Ortega-Sanchez, Mark L. Messonnier, William W. Thompson, Pascale M. Wortley, et al. The Annual Impact of Seasonal Influenza in the U.S.: Measuring disease burden and costs. Vaccine. 2007; 25: 5086-96. http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-14.pdf

Title: The Annual Impact of Seasonal Influenza in the U.S.: Measuring disease burden and costs
Publication: Vaccine
Publication Date: 2007
Authors: Molinari, Noelle-Angelique M., Ismael R. Ortega-Sanchez, Mark L. Messonnier, William W. Thompson, Pascale M. Wortley, et al.
Pages: 5086-96
URL: Read Full Resource

Lost productivity and healthcare visits due to flu
In one year (1995), influenza was responsible for more than: 200 million days of restricted activity 100 million days of bed disability 75 million work absenteeisms 22 million health care provider visits [ Get More Details ]
Significant increase of penicillin-resistant Streptococcus penumoniae
High-level penicillin-resistant Steptococcus pneumoniae increased 1,000-fold over 17 years. [ Get More Details ]
Patients hospitalized for sepsis experience poor outcomes
Compared with patients hospitalized with other diagnoses, patients hospitalized for sepsis/septicemia are: 1/2 as likely to be discharged home 2 times more likely to be discharged to other short-term care 3 times more… [ Get More Details ]
Annual incidence of pneumonia in Medicare population
In Medicare beneficiaries, the average cumulative annual incidence of any type of pneumonia was 47.4 per 1,000 from 2005 to 2007. [ Get More Details ]
Antibiotic resistance of Klebsiella pneumoniae on the rise
Resistance of Klebsiella pneumoniae to antibiotics has dramatically increased- from 5.3% to 11.6% for third generation cephalosporins (between 1999 and 2010), and from <0.1% to 4.5% for carbapenams (between 2002… [ Get More Details ]